Zurcher Kantonalbank (Zurich Cantonalbank) Incyte Corp Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Incyte Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 327,272 shares of INCY stock, worth $24.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

327,272

Previous 160,415 104.02%

Holding current value

$24.5 Million

Previous $10.6 Million 113.18%

% of portfolio

0.07%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$65.08 - $83.38 $10.9 Million - $13.9 Million	166,857 Added 104.02%	327,272 $22.6 Million
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $2.13 Million - $2.55 Million	37,132 Added 30.12%	160,415 $10.6 Million
Q2 2024 Jul 29, 2024	SELL	$51.18 - $63.75 $10.2 Million - $12.8 Million	-200,019 Reduced 61.87%	123,283 $7.47 Million
Q1 2024 Apr 25, 2024	SELL	$56.55 - $66.59 $703,086 - $827,913	-12,433 Reduced 3.7%	323,302 $18.4 Million
Q4 2023 Jan 30, 2024	BUY	$52.16 - $64.19 $4.47 Million - $5.5 Million	85,658 Added 34.25%	335,735 $21.1 Million
Q3 2023 Oct 25, 2023	BUY	$57.77 - $65.93 $7.05 Million - $8.05 Million	122,045 Added 95.32%	250,077 $14.4 Million
Q2 2023 Aug 07, 2023	BUY	$60.95 - $75.51 $5.68 Million - $7.03 Million	93,137 Added 266.91%	128,032 $7.97 Million
Q1 2023 May 08, 2023	SELL	$70.23 - $86.01 $4,845 - $5,934	-69 Reduced 0.2%	34,895 $2.52 Million
Q4 2022 Feb 01, 2023	SELL	$67.18 - $84.11 $338,855 - $424,250	-5,044 Reduced 12.61%	34,964 $2.81 Million
Q3 2022 Nov 09, 2022	SELL	$66.18 - $82.86 $594,230 - $743,999	-8,979 Reduced 18.33%	40,008 $2.67 Million
Q2 2022 Aug 09, 2022	SELL	$66.18 - $83.18 $2.02 Million - $2.54 Million	-30,517 Reduced 38.38%	48,987 $3.72 Million
Q1 2022 Apr 21, 2022	SELL	$66.02 - $79.71 $5.02 Million - $6.07 Million	-76,112 Reduced 48.91%	79,504 $6.31 Million
Q4 2021 Feb 01, 2022	SELL	$63.34 - $74.11 $1.87 Million - $2.19 Million	-29,543 Reduced 15.96%	155,616 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $8.32 Million - $10.2 Million	121,153 Added 189.28%	185,159 $12.7 Million
Q2 2021 Jul 30, 2021	BUY	$79.87 - $87.53 $854,289 - $936,220	10,696 Added 20.06%	64,006 $5.39 Million
Q1 2021 May 03, 2021	BUY	$76.02 - $100.5 $337,832 - $446,622	4,444 Added 9.09%	53,310 $4.33 Million
Q4 2020 Jan 28, 2021	BUY	$80.74 - $97.7 $107,061 - $129,550	1,326 Added 2.79%	48,866 $4.25 Million
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $463,716 - $597,920	-5,451 Reduced 10.29%	47,540 $4.27 Million
Q2 2020 Jul 28, 2020	BUY	$74.18 - $108.93 $360,885 - $529,944	4,865 Added 10.11%	52,991 $5.51 Million
Q1 2020 May 06, 2020	BUY	$63.18 - $85.97 $583,593 - $794,104	9,237 Added 23.75%	48,126 $3.52 Million
Q4 2019 Jan 21, 2020	BUY	$73.04 - $95.72 $21,912 - $28,716	300 Added 0.78%	38,889 $3.4 Million
Q3 2019 Oct 18, 2019	SELL	$72.82 - $86.52 $2,403 - $2,855	-33 Reduced 0.09%	38,589 $2.86 Million
Q2 2019 Jul 30, 2019	SELL	$73.52 - $88.7 $73,520 - $88,700	-1,000 Reduced 2.52%	38,622 $3.28 Million
Q1 2019 Apr 29, 2019	BUY	$63.56 - $88.17 $217,502 - $301,717	3,422 Added 9.45%	39,622 $3.41 Million
Q4 2018 Jan 25, 2019	SELL	$58.5 - $69.94 $409,500 - $489,580	-7,000 Reduced 16.2%	36,200 $2.3 Million
Q3 2018 Nov 09, 2018	BUY	$61.75 - $74.23 $30,875 - $37,115	500 Added 1.17%	43,200 $2.98 Million
Q1 2018 May 03, 2018	BUY	$83.06 - $100.98 $373,770 - $454,410	4,500 Added 11.78%	42,700 $3.56 Million
Q3 2017 Nov 08, 2017	BUY	$109.15 - $138.27 $4.17 Million - $5.28 Million	38,200	38,200 $4.46 Million

Others Institutions Holding INCY

# of Institutions

669

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Incyte Corp Transaction History